NBTX Stock Price History and Quote Analysis: Insights for Investors
Nanobiotix S.A.
Stock Price Today
Nanobiotix S.A. (NBTX) stock surged +4.43%, trading at $5.19 on NASDAQ, up from the previous close of $4.97. The stock opened at $5.12, fluctuating between $5.09 and $5.38 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.
Company Information
| Employees | 110 |
| Beta | 1.29 |
| Sales or Revenue | $30.06M |
| 5Y Sales Change% | 136.673% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Nanobiotix S.A. (NASDAQ: NBTX) stock price is $5.19 in the last trading session. During the trading session, NBTX stock reached the peak price of $5.38 while $5.09 was the lowest point it dropped to. The percentage change in NBTX stock occurred in the recent session was 4.43% while the dollar amount for the price change in NBTX stock was $0.22.
The NASDAQ listed NBTX is part of Biotechnology industry that operates in the broader Healthcare sector. Nanobiotix S.A. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Earl J. Bergey Ph.d.
Co-Founder
Ms. Kathryn M. McNeil
Senior Vice President of Investor Relations
Prof. Para Prasad Ph.D.
Co-Founder and Member of Scientific Board
Mr. Laurent Levy Ph.D.
Co-Founder, Pres of the Executive Board & Chief Executive Officer
Mr. Bart Van Rhijn
Chief Financial Officer & Member of Executive Board
Mr. Alain Dostie
Chief Operating Officer
Ms. Elsa Borghi
Head of Innovation & Drug Discovery
Ms. Anne-Juliette Hermant M.A.
Chief People Officer & Member of Executive Board
Ms. Sarah Gaubert
Head of Communication & Public Affairs Department
Ms. Margaret Galluzzi
Vice President & Global Head of Clinical Operations
Mr. Patrick Tricoli M.B.A., Pharm.D.
Global Head of Bus. Devel.
Mr. Ventzislav Vassilev M.D.
Vice President & Global Head of Safety Vigilance
NBTX's closing price is 25.36% higher than its 52-week low of $4.14 where as its distance from 52-week high of $8.96 is -42.09%.
Number of NBTX employees currently stands at 110.
Official Website of NBTX is: https://www.nanobiotix.com
NBTX could be contacted at phone 331 402 60470 and can also be accessed through its website. NBTX operates from 60 rue de Wattignies, Paris, 75012, France.
NBTX stock volume for the day was 13.67K shares. The average number of NBTX shares traded daily for last 3 months was 9.14K.
The market value of NBTX currently stands at $244.51M with its latest stock price at $5.19 and 47.11M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com